7111US Scl-70 (FDA cleared)
Intended Use:
AESKULISA Scl-70 is a solid phase enzyme immunoassay for the quantitative and qualitative detection of antibodies against Scl-70 (70 kDa scleroderma antigen) in human serum.
Recombinant Antigens:
Scl-70
Native Antigens:
n.a.
Published in
Rheumatology (FDA cleared Products)
Tagged under
) in the interactive HELIOS picture to activate detailed information regarding the serveral HELIOS features.